Myriad Genetics and MD Anderson partner to evaluate molecular residual disease assay

The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad’s molecular residual disease (MRD) assay.

Pfizer to cut 500 jobs at Sandwich, UK site

Another 500 jobs are on the chopping block as a result of Pfizer’s cost-cutting measures, this time at the company’s site in Sandwich, UK, where

November 15, 2023

Wheel Launches AI-Powered Platform for Virtual Care, Horizon

What You Should Know: – Wheel, a leading provider of telehealth and virtual care solutions, announces the launch of its AI-driven Horizon™ platform. – Horizon

June 12, 2024

Is long COVID triggering irritable bowel syndrome? Arizona study to investigate

The Arizona CoVHORT research study at the University of Arizona has received $3.2 million in funding to investigate the links between long COVID and gastrointestinal

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.